Abstract
A series of heteroaryl-substituted quinoxaline and quinoline derivatives, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions, said substituted derivatives having the general formula
Author supplied keywords
- Anabolic-Drug
- Antiinflammatory-Drug
- Antineoplastic-Drug
- Cardiovascular-Drug
- Enzyme Inhibitor-Drug
- Immunologic-Drug
- Metabolic-Drug
- Neoplasms - Therapeutic agents and therapy
- Neuroprotectant-Drug
- Ophthalmic-Drug
- Pathology - Therapy
- Pharmacology
- Pharmacology - Cardiovascular system
- Pharmacology - Connective tissue, bone and collage
- Pharmacology - Drug metabolism and metabolic stimu
- Pharmacology - General
- Pharmacology - Immunological processes and allergy
- Pharmacology - Neuropharmacology
- Pharmacology - Sense organs, associated structures
Cite
CITATION STYLE
Allen, D. R. [Inventor], [Author], A., Buckley, G. M. [Inventor], Burli, R. [Inventor], Davenport, J. R. [Inventor], Kinsella, N. [Inventor], … Williams, S. C. [Inventor]. (2013). Quinoxaline and quinoline derivatives as kinase inhibitors. Official Gazette of the United States Patent & Trademark Office Patents. Retrieved from http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=biop39&NEWS=N&AN=PREV201300383469
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
